ASCARIS LUMBRICOIDES INFECTION

Clinical trials for ASCARIS LUMBRICOIDES INFECTION explained in plain language.

Never miss a new study

Get alerted when new ASCARIS LUMBRICOIDES INFECTION trials appear

Sign up with your email to follow new studies for ASCARIS LUMBRICOIDES INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 1

Mass drug showdown: which treatment better fights river blindness?

Disease control Recruiting now

This large study in Angola compares two approved drugs—moxidectin and ivermectin—to see which works better when given annually to entire communities to control river blindness. Researchers will treat 52,000 people across 20 village groups for four years to measure how well each d…

Matched conditions: ASCARIS LUMBRICOIDES INFECTION

Phase: PHASE4 • Sponsor: Kirby Institute • Aim: Disease control

Last updated Mar 30, 2026 14:29 UTC

ASCARIS LUMBRICOIDES INFECTION

Get alerted when new ASCARIS LUMBRICOIDES INFECTION trials appear

Mass drug showdown: which treatment better fights river blindness?